From StockNews.com: Pfizer Inc. (NYSE:PFE) early Tuesday posted disappointing fourth quarter results and offered a tepid outlook, amid weakening demand for some of its key drugs.
The New York City-based company reported Q4 EPS of $0.47, which was $0.04 worse than the Wall Street consensus estimate of $0.51. Revenues fell 3% from last year to $13.63 billion, also missing analysts’ $13.69 billion view.